Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
AR amplification
i
Other names:
AR, AIS, DHTR, HUMARA, NR3C4, SBMA, SMAX1, Androgen receptor
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
367
Related biomarkers:
Expression
Mutation
Others
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
AR amplification
Prostate Cancer
AR amplification
Prostate Cancer
enzalutamide
Resistant: B - Late Trials
enzalutamide
Resistant
:
B
enzalutamide
Resistant: B - Late Trials
enzalutamide
Resistant
:
B
AR amplification
Prostate Cancer
AR amplification
Prostate Cancer
abiraterone acetate
Resistant: B - Late Trials
abiraterone acetate
Resistant
:
B
abiraterone acetate
Resistant: B - Late Trials
abiraterone acetate
Resistant
:
B
AR amplification
Prostate Cancer
AR amplification
Prostate Cancer
docetaxel
Resistant: C3 – Early Trials
docetaxel
Resistant
:
C3
docetaxel
Resistant: C3 – Early Trials
docetaxel
Resistant
:
C3
AR amplification
Prostate Cancer
AR amplification
Prostate Cancer
darolutamide
Resistant: C3 – Early Trials
darolutamide
Resistant
:
C3
darolutamide
Resistant: C3 – Early Trials
darolutamide
Resistant
:
C3
AR amplification
Prostate Cancer
AR amplification
Prostate Cancer
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
nivolumab
Resistant: C3 – Early Trials
nivolumab
Resistant
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login